Filter Results :

Your search for Biopharma returned 202 reports

Sort by


Pharmaceutical Industry in China to 2020 - An In Depth Analysis of Multinational and Chinese Biopharma Companies, Industry Trends, Environment, Regulation, Market Drivers, Restraints, Opportunities & Challenges

01 Jul 2015  |  Published by:  Kelly Scientific Publications
“Pharmaceutical Industry in China to 2020: An In Depth Analysis of Multinational and Chinese Biopharma Companies, Industry Trends, Environment, Regulation, Market Drivers, Restraints, Opportunities & Challengess” provides a detailed investigation of the market size, segmentation, key playe...

$ 3,400.00

Read More

Biopharmaceuticals Markets in China

01 Jul 2015  |  Published by:  Asia Market Info and Dev Co.
China's demand for Biopharmaceuticals has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, c...

$ 4,000.00

Read More

PlasmaTech Biopharmaceuticals, Inc. (PTBI) - Financial and Strategic SWOT Analysis Review

16 Jun 2015  |  Published by:  GlobalData
PlasmaTech Biopharmaceuticals, Inc. (PTBI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt...

$ 125.00

Read More

CTI BioPharma Corp. (CTIC) - Financial and Strategic SWOT Analysis Review

08 Jun 2015  |  Published by:  GlobalData
CTI BioPharma Corp. (CTIC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse...

$ 125.00

Read More

Sino Biopharmaceutical Limited (1177) - Financial and Strategic SWOT Analysis Review

07 Jun 2015  |  Published by:  GlobalData
SummarySino Biopharmaceutical Limited (Sino) is a pharmaceutical company. The company operates through Chinese Medicines and Chemical Medicines segment, Investment Segment, and Other Segments. Its Chinese medicines and chemical medicines segment manufactures, sells and distributes modernized Chinese...

$ 300.00

Read More

Provectus Biopharmaceuticals, Inc. (PVCT) - Financial and Strategic SWOT Analysis Review

07 Jun 2015  |  Published by:  GlobalData
SummaryProvectus Biopharmaceuticals, Inc. (Provectus) is a pharmaceutical company. The company develops and offers oncology therapies. Its products include PV-10 for melanoma, PH-10 for psoriasis, PH-10 for atopic dermatitis, PV-10 for metastatic liver cancer, PV-10 for recurrent breast cancer and P...

$ 300.00

Read More

Can-Fite BioPharma Ltd. (CFBI) - Financial and Strategic SWOT Analysis Review

07 Jun 2015  |  Published by:  GlobalData
SummaryCan-Fite BioPharma Ltd. (Can-Fite) is a biopharmaceutical company. It undertakes the discovery and clinical development of pharmaceutical products utilizing its platform technology. The company focuses on developing drugs that are used in the treatment of diseases such as cancer, sexual dysfu...

$ 300.00

Read More

Galena Biopharma, Inc. (GALE) - Financial and Strategic SWOT Analysis Review

07 Jun 2015  |  Published by:  GlobalData
SummaryGalena Biopharma, Inc. (Galena) is a biotechnology company. The company discovers, develops and commercializes therapies for the treatment of unmet medical needs, and advance care. Its products include Abstral, NeuVax, NeuVax Herceptin, and folate binding protein. The company provides NeuVax ...

$ 300.00

Read More

Synmosa Biopharma Corporation (4114) - Financial and Strategic SWOT Analysis Review

07 Jun 2015  |  Published by:  GlobalData
SummarySynmosa Biopharma Corporation (Synmosa) is a fully integrated specialty pharmaceutical company. It manufactures, markets and distributes ethical, over-the-counter (OTC) and healthcare products. It also produces non-pharmaceutical products such as cosmeceutical and nutrition products, and food...

$ 300.00

Read More

Integrated BioPharma, Inc. (INBP) - Financial and Strategic SWOT Analysis Review

07 Jun 2015  |  Published by:  GlobalData
SummaryIntegrated BioPharma, Inc. (IBI) is a biopharmaceutical company. The company develops and distributes nutritional supplement products and services. Its portfolio includes vitamin C, vitamin B12, acerola extract, vitamin E, ropufa, lycopene, acidulants, folic acid, emulsifiers, carotenoids, su...

$ 300.00

Read More

RegeneRx Biopharmaceuticals, Inc. (RGRX) - Financial and Strategic SWOT Analysis Review

07 Jun 2015  |  Published by:  GlobalData
SummaryRegeneRx Biopharmaceuticals, Inc. (RegeneRx Biopharmaceuticals) is a biopharmaceutical company. The company designs, researches and develops peptides targeted at diseases with unmet medical needs. Its pharmaceuticals protect and repair tissue and organ damage caused by disease, trauma or othe...

$ 300.00

Read More

Synageva BioPharma Corp. (GEVA) - Financial and Strategic SWOT Analysis Review

07 Jun 2015  |  Published by:  GlobalData
SummarySynageva BioPharma Corp. (Synageva), formerly known as AviGenics, Inc., is a biopharmaceutical company that focuses on discovering, developing and delivering medicines. It offers its products for patients with rare disease and unmet medical needs. The company’s pipeline products include Kanum...

$ 300.00

Read More

Sunshine Biopharma, Inc. (SBFM) - Financial and Strategic SWOT Analysis Review

07 Jun 2015  |  Published by:  GlobalData
SummarySunshine BioPharma, Inc. (Sunshine BioPharma) is a pharmaceutical company. The company conducts research, development and commercialization of drugs for the treatment of various forms of cancer. Its initial drug candidate is Adva-27a, which is a small molecule that has proven efficient agains...

$ 300.00

Read More

HanAll Biopharma Co., Ltd. (009420) - Financial and Strategic SWOT Analysis Review

07 Jun 2015  |  Published by:  GlobalData
SummaryHanAll Biopharma Co., Ltd. (HanAll) is a pharmaceutical company. The company’s activities include drug delivery, biotherapeutics, and small molecule discovery. Its research and development pipeline includes HL156Can, HL152B, HL156Fib, hanferon, HL036 topical TNF-alpha inhibitor, HL161 anti-Fc...

$ 300.00

Read More

ARCA biopharma, Inc. (ABIO) - Financial and Strategic SWOT Analysis Review

07 Jun 2015  |  Published by:  GlobalData
SummaryARCA biopharma, Inc. (ARCA biopharma) is a biopharmaceutical company. The company develops genetically-targeted therapies for the cardiovascular diseases. It focuses on develop personalized therapies for the treatment of cardiovascular disease through the use of genetics. ARCA biopharma’s pro...

$ 300.00

Read More
Total 202 records.